Macrolide resistance in Helicobacter pylori: Rapid detection of point mutations and assays of macrolide binding to ribosomes

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 12, 1997, Pages 2724-2728

  Occhialini, Alessandra ^a   Urdaci, Maria ^b   Doucet Populaire, Florence ^c,d   Bébéar, Cécile Marie ^a   Lamouliatte, Hervé ^e   Mégraud, Francis ^a  

^a HÔPITAL PELLEGRIN   (France)

^b Laboratoire de Microbiologie   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d CENTRE HOSPITALIER DE VERSAILLES   (France)

^e HÔPITAL SAINT ANDRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; MACROLIDE;

ANTIBIOTIC RESISTANCE; ARTICLE; DNA DETERMINATION; DRUG BINDING; HELICOBACTER PYLORI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RNA GENE; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; STRUCTURE ACTIVITY RELATION;

EID: 0030834006     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.12.2724     Document Type: Article

References (35)

1. Akopyants, N., N. O. Bukanov, T. U. Westblom, S. Kresovich, and D. E. Berg. 1992. DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. Nucleic Acids Res. 20:5137-5142.
2. Arthur, M., C. Molinas, C. Mabilat, and P. Courvalin. 1990. Detection of erythromycin resistance by the polymerase chain reaction using primers in conserved regions of erm rRNA methylase genes. Antimicrob. Agents Chemother. 34:2024-2026.
3. Bukanov, N. O., and D. E. Berg. 1994. Ordered cosmid library and high-resolution physical-genetic map of Helicobacter pylori strain NCTC11638. Mol. Microbiol. 11:509-523.
4. Cornaglia, G., M. Ligozzi, A. Mazzariol, M. Valentini, G. Orefici, the Italian Surveillance Group for Antimicrobial Resistance, and R. Fontana. 1996. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. Emerg. Infect. Dis. 2:339-342.
5. Debets-Ossenkopp, Y. J., M. Sparrius, J. G. Kusters, J. J. Kolkman, and C. M. J. E. Vandenbroucke-Grauls. 1996. Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. FEMS Microbiol. Lett. 142:37-42.
6. Doucet-Populaire, F., C. Truffot-Pernot, J. Grosset, and V. Jarlier. 1995. Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin. J. Antimicrob. Chemother. 36:129-136.
7. Douthwaite, S. 1992. Functional interactions within 23S rRNA involving the peptidyltransferase center. J. Bacteriol. 174:1333-1338.
8. European Helicobacter pylori Study Group. 1997. Current European concepts in the management of Helicobacter pylori infection. Gut 41:8-13.
9. Forman, D. 1992. Helicobacter pylori and gastric carcinogenesis Eur. J. Gastroenterol. Hepatol. 4(Suppl. 2):531-535.
10. Goldman, R. C., and S. K. Kadam. 1989. Binding of novel macrolide structures to macrolides-lincosamides-streptogramin B-resistant ribosomes inhibits protein synthesis and bacterial growth. Antimicrob. Agents Chemother. 33:1058-1066.
11. Goldman, R. C., D. Zakula, R. Flamm, J. Beyer, and J. Capobianco. 1994. Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. Antimicrob. Agents Chemother. 38:1496-1500.
12. Haas, C. E., D. E. Nix, and J. J. Schentag. 1990. In vitro selection of resistant Helicobacter pylori. Antimicrob. Agents Chemother. 34:1637-1641.
13. Hua, J., C. Birac, and F. Mégraud. 1996. PCR-based RAPD (random amplified polymorphic DNA) "fingerprinting" of clinical isolates of Helicobacter pylori, p. 121-127. In A. Lee, and F. Mégraud (ed.), Helicobacter pylori: techniques for clinical diagnosis & basic research-1996. Saunders, London, United Kingdom.
14. Leclercq, R., and P. Courvalin. 1991. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother. 35:1267-1272.
15. Lucier, T. S., K. Heitzmann, S.-K. Liu, and P.-C. Hu. 1995. Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 39:2772-2773.
16. Marshall, B. J., and J. R. Warren. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet i:1311-1314.
17. Mégraud, F. 1997. Resistance of Helicobacter pylori to antibiotics. Aliment. Pharmacol. Ther. 11:305-309.
18. Mégraud, F., C. Camou-Juncas, A. Occhialini, and C. Birac. 1996. Helicobacter pylori resistance levels to clarithromycin remain stable. Gastroenterology 100:A192.
19. Mégraud, F., and H. Lamouliatte. 1992. Helicobacter pylori and duodenal ulcer. Evidence suggesting causation. Dig. Dis. Sci. 37:769-772.
20. Meier, A., P. Kirschner, B. Springer, V. A. Steingrube, B. A. Brown, R. J. Wallace, Jr., and E. C. Böttger. 1994. Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob. Agents Chemother. 38:381-384.
21. Menninger, J. R. 1985. Functional consequences of binding macrolides to ribosomes. J. Mol. Biol. 16:23-24.
22. Nash, K. A., and C. B. Inderlied. 1995. Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. Antimicrob. Agents Chemother. 39:2625-2630.
23. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. 1994. Helicobacter pylori in peptic ulcer disease. JAMA 272:65-69.
24. Occhialini, A., M. Urdaci, F. Doucet-Populaire, C. M. Bébéar, H. Lamouliatte, and F. Mégraud. 1996. Helicobacter pylori resistance to macrolides. Confirmation of point mutation and detection by PCR-RFLP. Gut 39(Suppl. 2):A1.
25. Pernodet, J. L., F. Boccard, M. T. Alegre, M. H. Bondelet-Rouault, and M. Guérineau. 1988. Resistance to macrolides, lincosamides and streptogramin type B antibiotics due to a mutation in an rRNA operon of Streptomyces ambofaciens. EMBO J. 7:277-282.
26. Shortridge, V. D., R. K. Flamm, N. Ramer, J. Beyer, and S. K. Tanaka, 1996. Novel mechanism of macrolide resistance in Streptococcus pneumoniae. Diagn. Microbiol. Infect Dis. 26:73-78.
27. Sigmund, C. D., and E. A. Morgan. 1992. Erythromycin resistance due to a mutation in a ribosomal RNA operon of Escherichia coli. Proc. Natl. Acad. Sci. USA 79:5602-5606.
28. Steers, E., E. L. Foltz, B. S. Graves, and J. Riden. 1959. An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics. Antibiot. Chemother. (Washington, D.C.) 9:307-311.
29. Stone, G. G., D. Shortridge, R. K. Flamm, J. Versalovic, J. Beyer, K. Idler, L. Zulawinski, and S. K. Tanaka. 1996. Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori. Helicobacter 1:227-228.
30. Sutcliffe, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clarithromycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824.
31. Tomb, J.-F., G. Sutton, A. Glodek, L. Zhou, O. White, T. Utterback, J. Kelley, J. Peterson, R. Fleischmann, C. Bult, M. Adams, J. Gocayne, R. Clayton, N. Akopyants, D. E. Berg, H. O. Smith, C. Fraser, and J. C. Venter. 1996. The complete DNA sequence of the Helicobacter pylori genome. Gut 39(Suppl. 2):A3.
32. Vannuffel, P., M. Di-Giambattista, E. A. Morgan, and C. Cocito. 1992. Identification of a single base change in ribosomal RNA leading to erythromycin resistance. J. Biol. Chem. 267:8377-8382.
33. Versalovic, J., D. Shortridge, K. Kibler, M. V. Griffy, J. Beyer, R. K. Flamm, S. K. Tanaka, D. Y. Graham, and M. F. Go. 1996. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 40:477-480.
34. Vester, B., and R. A. Garrett. 1987. A plasmid-coded and site-directed mutation in Escherichia coli 23S RNA that confers resistance to erythromycin: implications for the mechanism of action of erythromycin. Biochimie 69:891-900.
35. Weisblum, B. 1995. Erythromycin resistance by ribosome modification. Antimicrob. Agents Chemother. 39:577-585.